XML 36 R25.htm IDEA: XBRL DOCUMENT v3.25.4
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2025
Fair Value Measurements [Abstract]  
Schedule of Company’s Assets and Liability that are Measured at Fair Value

The following table presents information about the Company’s assets and liability that are measured at fair value on a recurring basis at December 31, 2025 and 2024 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

 

Description  Level  December 31,
2025
   December 31,
2024
 
Assets:           
Marketable securities held in Trust Account 1  3,973,290   26,832,298 
Total marketable securities held in Trust Account 1 $3,973,290  $26,832,298 
Liability:             
Convertible promissory note and forward settlement contract – related party 3  11,007,174    
Schedule of Quantitative Information Regarding Market Assumptions Used in the Level 3 Valuation The following table presents the quantitative information regarding market assumptions used in the Level 3 valuation of the Second Amended and Restated Promissory Note and Forward Settlement Contract:
   July 29,
2025
   December 31,
2025
 
Estimated deSPAC stock price $5.76  $3.10 
Remaining term  1.7   1.7 
Volatility  102.4%  102.4%
Risk-free rate  3.85%  3.41%
Implied probability of successful initial Business Combination  70.0%  78.4%
Schedule of Changes in the Fair Value of the Company’s Level 3 Financial Instruments

The following table provides a summary of the changes in the fair value of Convertible Promissory Note and Forward Settlement Contract, a Level 3 financial instrument, that was measured at fair value on a recurring basis:

 

Fair value at July 29, 2025 $9,964,704 
Additional draws on promissory note and forward settlement contract  825,000 
Change in fair value of promissory note and forward settlement contract  217,470 
Fair value at December 31, 2025 $11,007,174